Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.
Pinhel IF, Macneill FA, Hills MJ, Salter J, Detre S, A'hern R, Nerurkar A, Osin P, Smith IE, Dowsett M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of cold ischemia time and surgical procedure type on IHC staining in breast cancer specimens.
Summary of Findings
Needle core biopsy specimens with an average room temperature cold ischemia time of 30 min (range 20-80 min) showed no significant differences in Ki67, ER, PR, p-Akt, p-Erk1/2, or HER2 IHC staining when compared to core-cuts that were fixed immediately. Comparison of needle core biopsy specimens (all cold ischemia times) with resection specimens showed comparable immunostaining for Ki67 and PR with a nonsignificant trend towards decreased staining for ER in resection specimens (p=0.06). While HER2 status was not influenced by the type of specimen, 12 of 15 specimens were graded as 1+ in the core-cut and a 0 in the resection. Significantly lower p-Akt and p-Erk1/2 immunostaining was observed in resected specimens than in core-cut specimens (p<0.0001). Interestingly, the average differences in staining were greater between core-cut and mastectomy specimens than core-cut and lumpectomy specimens, but this was only significant for p-Erk1/2 (p=0.01). Notably, mastectomy specimens were sliced prior to fixation to allow for penetration of formalin while lumpectomy specimens were left unsliced.
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Cold ischemia time 0 min20-80 minBiospecimen Acquisition Method of tissue acquisition Core needle biopsyLumpectomyMastectomySurgical resectionImmunohistochemistry Specific Targeted peptide/protein ERHER2Ki67PRp-Aktp-Erk1/2